These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 19929794)

  • 1. HIV-1 infection in subjects older than 70: a multicenter cross-sectional assessment in Catalonia, Spain.
    Mothe B; Perez I; Domingo P; Podzamczer D; Ribera E; Curran A; Viladés C; Vidal F; Dalmau D; Pedrol E; Negredo E; Moltó J; Paredes R; Perez-Alvarez N; Gatell JM; Clotet B
    Curr HIV Res; 2009 Nov; 7(6):597-600. PubMed ID: 19929794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of comorbidities in people living with HIV between 2004 and 2014: cross-sectional analyses from ANRS CO3 Aquitaine cohort.
    Bonnet F; Le Marec F; Leleux O; Gerard Y; Neau D; Lazaro E; Duffau P; Caubet O; Vandenhende MA; Mercie P; Cazanave C; Dabis F
    BMC Infect Dis; 2020 Nov; 20(1):850. PubMed ID: 33198667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2012 Jun; 30(6):e1-89. PubMed ID: 22633764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular risk factors and lifetime risk estimation in HIV-infected patients under antiretroviral treatment in Spain.
    Estrada V; Bernardino JI; Masiá M; Iribarren JA; Ortega A; Lozano F; Miralles C; Olalla J; Santos J; Elías MJ; Domingo P; Cruz AF
    HIV Clin Trials; 2015; 16(2):57-65. PubMed ID: 25874992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of antiretroviral treatment and nadir CD4 count in progression to cardiovascular events and related comorbidities in a HIV Brazilian cohort: a multi-stage approach.
    Oliveira RVC; Shimakura SE; Campos DP; Hökerberg YHM; Victoriano FP; Ribeiro S; Veloso VG; Grinsztejn B; Carvalho MS
    AIDS Care; 2018 May; 30(5):551-559. PubMed ID: 29058481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiological and clinical features, response to HAART, and survival in HIV-infected patients diagnosed at the age of 50 or more.
    Nogueras M; Navarro G; Antón E; Sala M; Cervantes M; Amengual M; Segura F
    BMC Infect Dis; 2006 Nov; 6():159. PubMed ID: 17087819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary human immunodeficiency virus type 1 infection: clinical, virological and immunological characteristics of 75 patients (1997-2003).
    Sued O; Miró JM; Alquezar A; Claramonte X; García F; Plana M; Arnedo M; de Lazzari E; Gil C; Manzardo C; Blanco JL; Martínez E; Mallolas J; Joseph J; Pumarola T; Gallart T; Gatell JM
    Enferm Infecc Microbiol Clin; 2006 Apr; 24(4):238-44. PubMed ID: 16725083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The burden of metabolic diseases amongst HIV positive patients on HAART attending The Johannesburg Hospital.
    Julius H; Basu D; Ricci E; Wing J; Basu JK; Pocaterra D; Bonfanti P
    Curr HIV Res; 2011 Jun; 9(4):247-52. PubMed ID: 21631427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and related drug cost of comorbidities in HIV-infected patients receiving highly active antiretroviral therapy in Taiwan: A cross-sectional study.
    Yang CJ; Wang HY; Chou TC; Chang CJ
    J Microbiol Immunol Infect; 2019 Oct; 52(5):720-727. PubMed ID: 31358463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comorbidities and cardiovascular risk factors in an aged cohort of HIV-infected patients on antiretroviral treatment in a Spanish hospital in 2016.
    Fontela C; Castilla J; Juanbeltz R; Martínez-Baz I; Rivero M; O'Leary A; Larrea N; San Miguel R
    Postgrad Med; 2018 Apr; 130(3):317-324. PubMed ID: 29486621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Aging and HIV infection: 4 years follow-up of 149 HIV infected patients older than 60 years in West Paris agglomeration (COREVIH Île-de-France Ouest)].
    Flexor G; Zucman D; Berthé H; Meier F; Force G; Greder-Belan A; Billy C; Dupont C; Mortier E; Bizard A; Rouveix E; de Truchis P;
    Presse Med; 2013 May; 42(5):e145-52. PubMed ID: 23433913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of drug resistance genotypes on CD4+ counts and plasma viremia in heavily antiretroviral-experienced HIV-infected patients.
    Rodes B; García F; Gutierrez C; Martinez-Picado J; Aguilera A; Saumoy M; Vallejo A; Domingo P; Dalmau D; Ribas MA; Blanco JL; Pedreira J; Perez-Elias MJ; Leal M; de Mendoza C; Soriano V;
    J Med Virol; 2005 Sep; 77(1):23-8. PubMed ID: 16032728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)].
    Panel de expertos de GESIDA y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2011 Mar; 29(3):209.e1-103. PubMed ID: 21388714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [HIV infection in patients aged 50 years or older in the HAART era].
    Villamil-Cajoto I; Losada-Arias E; Prieto-Martínez A; Lires-Moledo C; Quintela-Vázquez P
    Enferm Infecc Microbiol Clin; 2006; 24(6):382-4. PubMed ID: 16792941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiretroviral exposure and comorbidities in an aging HIV-infected population: The challenge of geriatric patients.
    Allavena C; Hanf M; Rey D; Duvivier C; BaniSadr F; Poizot-Martin I; Jacomet C; Pugliese P; Delobel P; Katlama C; Joly V; Chidiac C; Dournon N; Merrien D; May T; Reynes J; Gagneux-Brunon A; Chirouze C; Huleux T; Cabié A; Raffi F;
    PLoS One; 2018; 13(9):e0203895. PubMed ID: 30240419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overall trends in CD4 counts and plasma viremia in an urban clinic since the introduction of highly active antiretroviral therapies.
    Martín JC; Soriano V; Jiménez-Nácher I; Martínez P; González-Lahoz J
    Clin Microbiol Infect; 2001 Dec; 7(12):678-81. PubMed ID: 11843909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study.
    Kaufmann GR; Perrin L; Pantaleo G; Opravil M; Furrer H; Telenti A; Hirschel B; Ledergerber B; Vernazza P; Bernasconi E; Rickenbach M; Egger M; Battegay M;
    Arch Intern Med; 2003 Oct; 163(18):2187-95. PubMed ID: 14557216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The HIV patient profile in 2013 and 2003: Results from the Greek AMACS cohort.
    Pantazis N; Chini M; Antoniadou A; Sambatakou H; Skoutelis A; Gargalianos P; Kourkounti S; Gogos C; Chrysos G; Psichogiou M; Sipsas NV; Katsarou O; Panagopoulos P; Metallidis S; Touloumi G;
    PLoS One; 2018; 13(9):e0203601. PubMed ID: 30208097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human immunodeficiency virus in an aging population, a complication of success.
    Kirk JB; Goetz MB
    J Am Geriatr Soc; 2009 Nov; 57(11):2129-38. PubMed ID: 19793157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moving from viral suppression to comprehensive patient-centered care: the high prevalence of comorbid conditions and health risk factors in HIV-1-infected patients in Australia.
    Broom J; Sowden D; Williams M; Taing K; Morwood K; McGill K
    J Int Assoc Physicians AIDS Care (Chic); 2012; 11(2):109-14. PubMed ID: 21876215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.